Delivery Order SPE2DB22D2108-SPE2DB24FU3TJ
Award Date
4/18/24
Potential Completion Date
4/19/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,316.49 Firm Fixed Price Delivery Order covers the supply of 4,567,751,489 units of the generic drug Glimepiride 2 mg tablets. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $1,018.25 firm fixed-price delivery order is for 4566437277 GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The award has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,143.31 firm-fixed-price delivery order is for 4,567,632,423 tablets of the medication Glimepiride 4 mg. The contract has an ultimate completion date of March 20, 2025 and was awarded on March 19, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 4 mg glimepiride tablets to the Defense Logistics Agency (DLA) under a firm-fixed price Delivery Order. The contract has a ceiling value of $2,300.67 and an ultimate completion date of March 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,119.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4 mg Glimepiride tablets in 100-count bottles. The contract has an ultimate completion date of January 27, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen is the prime contractor, and the contract is not designated as a set-aside. The...
This federal contract award is for the delivery of 4 mg Glimepiride tablets to the Defense Logistics Agency (DLA). The $7,283.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,626,104 Glimepiride 4 mg tablets. The firm-fixed-price delivery order, valued at $4,039.92, has an ultimate completion date of December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,247.78 firm fixed-price delivery order is for the supply of Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,225.83, is a delivery order for the supply of 4,567,751,376 tablets of the drug Glimepiride 2 mg. The contract has an ultimate completion date of April 1, 2025 and is a firm fixed-price contract type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,330.04 firm fixed price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...